Prognostic Factors for Survival in Patients Undergoing Surveillance After Cytoreductive Nephrectomy.
Stephen W ReeseSari KhaleelAndrew SilagyAmy XieLennert EismannKatiana Vazquez-RiveraArnold OparanozieSujata PatilJonathan ColemanRobert MotzerRitesh R KotechaPaul RussoMartin H VossA Ari HakimiPublished in: The Journal of urology (2023)
Using risk stratification based on IMDC and number of metastatic sites, surveillance in favorable-risk patients can be utilized for a period without the initiation of systemic therapy. This approach can delay patients' exposure to the side effects of systemic therapy.